Ironwood Pharmaceuticals Inc

IRWD · Moat type: REGULIERUNG

MoatScore

5/10

Fair Value

11 USD

Margin of Safety

+63.3 %

Rating

BEOBACHTEN

Ironwood Pharmaceuticals is a pharmaceutical company specializing in gastrointestinal disorders, which primarily generates license revenues and product sales from its core product for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.